Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Haleon - 2025" company profile has been added to ResearchAndMarkets.com's offering.
The report provides insights into the Haleon's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Haleon is a British consumer health company with an extensive product portfolio. The company categorized its brands into five categories namely, Oral Health; Pain; Vitamins, Minerals and Supplements (VMS); Respiratory; and Digestive and Other. Its Oral Health product portfolio includes Sensodyne, Polident, Parodontax, Biotene, and Aquafresh. Its Pain relief product portfolio includes Panadol, Voltaren, and Advil. Its VMS product portfolio includes Centrum, Caltrate, and Emergen-C. Its Digestive and Other product portfolio includes TUMS, ENO, and Fenistil. Its Respiratory product portfolio includes Otrivine, Flonase, and Theraflu. Haleon's products are available in North America, the Asia-Pacific region (APAC), Europe, the Middle East and Africa (EMEA) region, and Latin America (LATAM).
The report provides information and insights into Haleon's tech activities, including:
Reasons to Buy
Key Topics Covered:
Company Coverage Includes:
For more information about this company profile visit https://www.researchandmarkets.com/r/b5g7wi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.